Submitted by Anonymous (not verified) on 8 November 2023 - 9:56
Human medicines European public assessment report (EPAR): Relvar Ellipta, fluticasone furoate,vilanterol, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 13/11/2013, Revision: 25, Status: Authorised
Source: